| Application no. and date | 12727767.1 (espacenet) (Federated) (European Patent Register), 20120614 | | Patent/reg. no. and date | DK/EP 2721065, 20180912 | | Publication date | 20140423 | | Priority no. and date | US 201161498518 P, 20110617, US 201161578309 P, 20111221 | | EP pub. no. and date |
EP 2721065 20140423 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | P81804439DK00E | | Inventor | MURPHY, Andrew, J., 10 Newton Court
Croton-On-Hudson, NY 10520, US,
GUSAROVA, Viktoria, 131 Sky Top Drive
Pleasantville, NY 10570, US,
SLEEMAN, Mark, W., 2 Albert Place
Richmond,
Victoria 3121, AU | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 3/06 (2006.01) , C07K 16/22 (2006.01) | | Title | Anti-ANGPTL3-antistoffer og anvendelser | | Int. application no. | US2012042338 | | Int. publication no. | WO2012174178 | | Related patent (certificate) | CA 2021 00029 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
